LINCOLN PHARMACEUTICALS
|
The Current P/S Ratio of LINCOLN PHARMACEUTICALS is 1.50.
| Share Price | ₹475.2 | Dec 18,2025 |
| Market Cap | ₹950.4 Cr | |
| Sales-TTM | ₹632.2 Cr | TTM-Consolidated Results |
| Price/Sales | 1.50x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of LINCOLN PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹950.4 Cr] as on Dec 18,2025
(/) Sales [ ₹632.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.50x ]
Thus, for LINCOLN PHARMACEUTICALS , the investors are currently willing to pay '1.50 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of LINCOLN PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of LINCOLN PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of LINCOLN PHARMACEUTICALS
PS Ratio Performance Analysis for LINCOLN PHARMACEUTICALS
- LINCOLN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.50x.
- LINCOLN PHARMACEUTICALS 's operated at median p/e ratio of 1.33x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LINCOLN PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 2.02x.
- LINCOLN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 1.06x.
How does LINCOLN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| LINCOLN PHARMACEUTICALS | 632.2 | 1.50 | 950.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.62 | 418,708.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 17.15 | 171,975.0 |
| CIPLA LTD | 28,349.6 | 4.32 | 122,539.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.50 | 128,619.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.11 | 106,741.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.61 | 89,743.8 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.78 | 92,558.4 |
| LUPIN LTD | 24,750.7 | 3.92 | 97,101.7 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.19 | 71,133.7 |
| ABBOTT INDIA LTD | 6,714.4 | 8.87 | 59,581.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LINCOLN PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.50x |
| Max industry PS | 17.15x |
| Median industry PS | 4.32x |
| Average industry PS | 6.32x |
You may also like the below Video Courses